ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.7919
0.00%
Brent Oil
80.005
0.00%
Bitcoin
103,885.40
-0.23%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. China SXT Pharmaceuticals Inc (SXTC)

  7. China SXT Pharmaceuticals Inc (SXTC) Noticias

SXTC

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SXTC
FechaHoraFuenteTítuloSímboloCompañía
04/11/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SXTCChina SXT Pharmaceuticals Inc
25/10/202411:19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
22/10/202415:51Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:SXTCChina SXT Pharmaceuticals Inc
15/10/202415:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
07/10/202415:15GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyNASDAQ:SXTCChina SXT Pharmaceuticals Inc
13/08/202415:15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SXTCChina SXT Pharmaceuticals Inc
31/07/202415:15Edgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNASDAQ:SXTCChina SXT Pharmaceuticals Inc
11/01/202415:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SXTCChina SXT Pharmaceuticals Inc
26/10/202315:05GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
04/10/202307:30GlobeNewswire Inc.China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
19/05/202316:17Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
10/05/202307:00GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleNASDAQ:SXTCChina SXT Pharmaceuticals Inc
29/03/202313:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
29/03/202312:50Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
27/03/202305:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
28/02/202315:06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
18/07/202210:02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
18/05/202211:30GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
16/03/202207:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
15/03/202215:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
14/03/202221:33GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 MillionNASDAQ:SXTCChina SXT Pharmaceuticals Inc
20/01/202209:45GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-AllotmentNASDAQ:SXTCChina SXT Pharmaceuticals Inc
18/01/202205:47GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary SharesNASDAQ:SXTCChina SXT Pharmaceuticals Inc
14/01/202216:43GlobeNewswire Inc.China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary SharesNASDAQ:SXTCChina SXT Pharmaceuticals Inc
14/01/202213:30PR Newswire (US)China SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of LuxuejinNASDAQ:SXTCChina SXT Pharmaceuticals Inc
18/10/202107:00PR Newswire (US)China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-InspectionNASDAQ:SXTCChina SXT Pharmaceuticals Inc
19/02/202107:00PR Newswire (US)China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share SplitNASDAQ:SXTCChina SXT Pharmaceuticals Inc
11/02/202105:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
09/09/202008:00PR Newswire (US)NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain Compliance with Bid Price RequirementNASDAQ:SXTCChina SXT Pharmaceuticals Inc
22/05/202014:50Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:SXTCChina SXT Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SXTC

Su Consulta Reciente

FX
EURUSD
Euro vs US Dollar
NASDAQ
AMZN
Amazon.com
NYSE
XOM
Exxon Mobil
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
COIN
AVAXUSD
Avalanche
AMEX
XLF
Financial Select Sector
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
CCOM
US500
US 500
COIN
DOGEUSD
Dogecoin
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
NASDAQ
TSLA
Tesla
NYSE
AXP
American Express
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados